Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon

NCT00251238 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Raynaud Disease

Interventions

DRUG: Ginkgo biloba extract EGb 761

Sponsor

VSM Geneesmiddelen b.v.